Roundtable Discussion: Preclinical to Early Phase Research Considerations

Time: 10:45 am
day: Day 2 Track A AM


  • What are the implications for advances in models and discovery for future drug research?
  • How can we address the roadblocks in moving to early phase studies?
  • How can clinical trial design and biomarker implementation be optimized in neuropsychiatry?